WebThe Acute Kidney Injury (AKI) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. WebApr 30, 2024 · RESCAP (Rescuing Alkaline Phosphatase), is an endogenous enzyme based on Alkaline Phosphatase (AP) a naturally occurring protein present in the body. It works as prophylactic and therapeutic...
Acute Kidney Injury (AKI) Market Study, 2024-2030 – Featuring …
WebFeb 14, 2024 · The Acute Kidney Injury epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Incident Population of Acute Kidney Injury (AKI) in... WebThe safety and efficacy of bRESCAP has been established in a variety of preclinical disease models and in a clinical trials, either IV or SC formulations. The Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase (APPIRED-III; NCT03050476) study of RESCAP is a Phase III study in cardiothoracic surgery patients. gofounders log in
30+ Active Companies working to develop 30+ Pipeline Therapies …
WebApr 30, 2024 · The Acute Kidney Injury (AKI) market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and … WebApr 13, 2024 · Key Acute Kidney Injury Pipeline Therapies: bRESCAP, ANG-3777, EA-230, Ilofotase alfa, ASP1128, Ruconest (Conestat alfa), and others. Dive deep into rich insights for drugs for Acute Kidney... WebJun 21, 2024 · The Acute Kidney Injury therapies in the pipeline include bRESCAP, ANG-3777, EA-230, Ilofotase alfa, ASP1128, Ruconest (Conestat alfa), and others. The key driver for the surge in acute kidney... go fotboll